BioAdvance News

Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride

By WebmasterJuly 28, 2011November 1st, 2024No Comments

Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride
Read more here

Previous PostYaupon Therapeutics, Inc. Secures $14.4 Million in Series D Financing
Next PostYaupon Therapeutics, Inc. Appoints New Management Team